Shopping Cart
- Remove All
- Your shopping cart is currently empty
PS10 is a broad-spectrum PDK inhibitor that inhibits PDK2, PDK4, PDK1, and PDK3. It significantly increases pyruvate dehydrogenase complex activity, and is used in research on obesity and type 2 diabetes.
Description | PS10 is a broad-spectrum PDK inhibitor that inhibits PDK2, PDK4, PDK1, and PDK3. It significantly increases pyruvate dehydrogenase complex activity, and is used in research on obesity and type 2 diabetes. |
Targets&IC50 | PDK2:0.8 μM, PDK3:2.1 μM, PDK4:0.76 μM, PDK1:21.3 μM |
In vitro | PS10 is a pan-PDK inhibitor with IC50 of 0.8 μM, 0.76 μM, 2.1 μM and 21.3 μM for PDK2, PDK4, PDK1 and PDK3, respectively. The Kd value combined with PDK2 is 239 nM. [1] |
In vivo | PS10 (70 mg/kg/ day for 3 days) stimulated PDC activity in DIO mice, increased glucose tolerance and reduced hepatic steatosis in DIO mice. [1] PS10 (70 mg/kg/ day, 4 weeks, intraperitoneal injection), mice showed significant improvements in glucose, insulin, and pyruvate tolerance, lower plasma insulin levels, and increased liver insulin signaling. [2] |
Alias | PS 10 |
Molecular Weight | 323.32 |
Formula | C14H13NO6S |
Cas No. | 1564265-82-2 |
Smiles | O=S(=O)(C1=CC=C(O)C=C1O)N2CC=3C=C(O)C=C(O)C3C2 |
Relative Density. | 1.696 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 50 mg/mL (154.65 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.